Ebix And CorEnergy Infrastructure Trust On The List Of Winners And Losers Of Wednesday’s US Session

(VIANEWS) – Another day of trading has ended and here’s today‚Äôs list of stocks that have had significant trading activity in the US session.

The three biggest winners today are Ebix, Arcturus Therapeutics, and Aspen Group.

Rank Financial Asset Price Change Updated (EST)
1 Ebix (EBIX) 1.83 14.06% 2023-12-19 12:26:59
2 Arcturus Therapeutics (ARCT) 31.83 11.01% 2023-12-19 12:31:06
3 Aspen Group (ASPU) 0.17 8.9% 2023-12-19 12:17:06
4 Nikola (NKLA) 0.88 7.37% 2023-12-19 12:32:12
5 Marathon (MARA) 21.16 6.44% 2023-12-19 12:28:42
6 Customers Bancorp (CUBI) 57.23 6.38% 2023-12-19 15:14:05
7 Bionano Genomics (BNGO) 1.62 6.25% 2023-12-19 12:31:16
8 American Public Education (APEI) 8.93 6.18% 2023-12-19 12:25:47
9 Pacific Biosciences of California (PACB) 9.76 6.15% 2023-12-19 12:29:19
10 Groupon (GRPN) 11.67 5.69% 2023-12-19 12:27:56

The three biggest losers today are CorEnergy Infrastructure Trust, FuelCell Energy, and City Office REIT.

Rank Financial Asset Price Change Updated (EST)
1 CorEnergy Infrastructure Trust (CORR) 0.19 -11.32% 2023-12-19 13:08:06
2 FuelCell Energy (FCEL) 1.40 -8.5% 2023-12-19 12:12:53
3 City Office REIT (CIO) 5.82 -7.47% 2023-12-19 09:14:05
4 Chesapeake Granite Wash Trust (CHKR) 0.62 -6.42% 2023-12-19 07:49:06
5 Atrion (ATRI) 340.00 -6.08% 2023-12-19 12:25:55
6 Coeur Mining (CDE) 3.40 -3.95% 2023-12-19 07:09:06
7 Coeur Mining (CDE) 3.40 -3.95% 2023-12-19 07:09:06
8 China Green Agriculture (CGA) 2.02 -3.8% 2023-12-19 07:43:05
9 FAT Brands (FAT) 6.18 -3.44% 2023-12-19 12:17:58
10 Lyft (LYFT) 15.15 -3.13% 2023-12-19 12:32:00

Winners today

1. Ebix (EBIX) – 14.06%

Ebix, Inc., together with its subsidiaries, provides on-demand infrastructure software exchanges and e-commerce services to the insurance, financial, travel, cash remittance, and healthcare industries in the United States and internationally. The company develops and deploys insurance and reinsurance exchanges on an on-demand basis using software-as-a-service (SaaS) enterprise solutions in the areas of customer relationship management, front-end and back-end systems, and outsourced administrative and risk compliance solutions. Its EbixCash exchange related products and services include gift cards; travel exchanges services; money transfer services; foreign exchange and outward remittance services; consumer payment services; and on-demand technology to various providers in the areas of lending, wealth and asset management, and travel. The company's insurance exchanges related products and services include SaaS platform and related services; licensing of software; and professional services comprising setup, customization, training, or consulting. Its risk compliance services cover certificates of insurance creation and tracking; consulting services, such as project management, integration, development, and testing; and business process outsourcing services, including domain intensive project management, system consulting services, and claims adjudication/settlement services. The company was formerly known as Delphi Systems, Inc. and changed its name to Ebix, Inc. in December 2003. Ebix, Inc. was founded in 1976 and is headquartered in Johns Creek, Georgia.

NASDAQ ended the session with Ebix rising 14.06% to $1.83 on Wednesday, after two consecutive sessions in a row of losses. NASDAQ rose 0.66% to $15,003.22, after five successive sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, Ebix has a trailing twelve months EPS of $0.16.

PE Ratio

Ebix has a trailing twelve months price to earnings ratio of 11.41. Meaning, the purchaser of the share is investing $11.41 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.49%.

Growth Estimates Quarters

The company’s growth estimates for the present quarter is a negative 161.5% and positive 21.7% for the next.

Sales Growth

Ebix’s sales growth is negative 53.8% for the present quarter and negative 47.2% for the next.

Volatility

Ebix’s last week, last month’s, and last quarter’s current intraday variation average was a positive 4.02%, a negative 0.19%, and a positive 6.55%.

Ebix’s highest amplitude of average volatility was 9.43% (last week), 6.46% (last month), and 6.55% (last quarter).

More news about Ebix.

2. Arcturus Therapeutics (ARCT) – 11.01%

Arcturus Therapeutics Holdings Inc., a late-stage clinical messenger RNA medicines and vaccine company, focuses on the development of infectious disease vaccines and other products within liver and respiratory rare diseases. Its technology platforms include LUNAR lipid-mediated delivery and STARR mRNA. The company is developing ARCT-810 (LUNAR-OTC), a mRNA-based therapeutic candidate, which is in Phase 2 clinical trial for treating ornithine transcarbamylase deficiency; and ARCT-154 (LUNAR-COV19), a mRNA vaccine candidate that is in Phase 3 arm of a Phase 1/2/3 study in Vietnam for the treatment of COVID-19, as well as ARCT-032 (LUNAR-CF), a mRNA therapeutic candidate for cystic fibrosis. The company was founded in 2013 and is headquartered in San Diego, California.

NASDAQ ended the session with Arcturus Therapeutics rising 11.01% to $31.83 on Wednesday, following the last session’s downward trend. NASDAQ jumped 0.66% to $15,003.22, after five consecutive sessions in a row of gains, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, Arcturus Therapeutics has a trailing twelve months EPS of $3.76.

PE Ratio

Arcturus Therapeutics has a trailing twelve months price to earnings ratio of 8.46. Meaning, the purchaser of the share is investing $8.46 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 46.66%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Arcturus Therapeutics’s stock is considered to be oversold (<=20).

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is a negative 121.4% and a negative 154.5%, respectively.

Volatility

Arcturus Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was 7.41%, 0.80%, and 3.59%.

Arcturus Therapeutics’s highest amplitude of average volatility was 7.41% (last week), 3.70% (last month), and 3.59% (last quarter).

Volume

Today’s last reported volume for Arcturus Therapeutics is 289434 which is 27.94% below its average volume of 401685.

More news about Arcturus Therapeutics.

3. Aspen Group (ASPU) – 8.9%

Aspen Group, Inc., an education technology company, provides online higher education services in the United States. The company offers baccalaureate, master's, and doctoral degree programs in nursing and health sciences, business and technology, arts and sciences, and education fields through Aspen University and United States University. As of April 30, 2022, it had 13,334 degree-seeking students enrolled. Aspen Group, Inc. was founded in 1987 and is based in New York, New York.

NASDAQ ended the session with Aspen Group jumping 8.9% to $0.17 on Wednesday, following the last session’s upward trend. NASDAQ rose 0.66% to $15,003.22, after five successive sessions in a row of gains, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, Aspen Group has a trailing twelve months EPS of $-0.38.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.26%.

More news about Aspen Group.

4. Nikola (NKLA) – 7.37%

Nikola Corporation operates as a technology innovator and integrator that develops energy and transportation solutions. It operates through two business units, Truck and Energy. The Truck business unit develops and commercializes battery electric vehicles (BEV) and hydrogen fuel cell electric vehicles (FCEV) to the trucking sector. The Energy business unit develops and constructs a network of hydrogen fueling stations; and offers BEV charging solutions for its FCEV and BEV customers, as well as other third-party customers. The company also assembles, integrates, and commissions its vehicles in collaboration with its business partners and suppliers. Nikola Corporation founded in 2015 and is headquartered in Phoenix, Arizona.

NASDAQ ended the session with Nikola jumping 7.37% to $0.88 on Wednesday, after two successive sessions in a row of losses. NASDAQ jumped 0.66% to $15,003.22, after five sequential sessions in a row of gains, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, Nikola has a trailing twelve months EPS of $-1.61.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -159.83%.

More news about Nikola.

5. Marathon (MARA) – 6.44%

Marathon Digital Holdings, Inc. operates as a digital asset technology company that mines digital assets with a focus on the blockchain ecosystem and the generation of digital assets in United States. The company was formerly known as Marathon Patent Group, Inc. and changed its name to Marathon Digital Holdings, Inc. in February 2021. Marathon Digital Holdings, Inc. was incorporated in 2010 and is headquartered in Fort Lauderdale, Florida.

NASDAQ ended the session with Marathon rising 6.44% to $21.16 on Wednesday while NASDAQ rose 0.66% to $15,003.22.

Earnings Per Share

As for profitability, Marathon has a trailing twelve months EPS of $-3.08.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -42.13%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Marathon’s EBITDA is 12.64.

Moving Average

Marathon’s value is way above its 50-day moving average of $9.20 and way higher than its 200-day moving average of $10.51.

More news about Marathon.

6. Customers Bancorp (CUBI) – 6.38%

Customers Bancorp, Inc. operates as the bank holding company for Customers Bank that provides financial products and services to individual consumers, and small and middle market businesses. It operates in two segments, Customers Bank Business Banking and BankMobile. The company accepts various deposit products, such as checking, savings, money market deposit, time deposit, non-interest-bearing demand accounts, individual retirement accounts, and other deposit accounts, as well as non-retail time deposits. It also provides commercial and industrial lending services; small business administration and paycheck protection program loans; multi-family and commercial real estate loans; commercial loans to mortgage companies; equipment financing services and specialty lending; mortgage warehouse loans; and home equity and residential mortgage and installment loans. In addition, the company offers private banking services; mobile phone banking, internet banking, wire transfers, electronic bill payment, lock box, remote deposit capture, courier, merchant processing, cash vault, controlled disbursements, and positive pay services; and cash management services, such as account reconciliation, collections, and sweep accounts. It operates 12 full-service branches, as well as limited production and administrative offices in Southeastern Pennsylvania, including Bucks, Berks, Chester, Philadelphia, and Delaware Counties; Rye Brook and New York; Hamilton, New Jersey; Boston, Massachusetts; Providence, Rhode Island; Portsmouth, New Hampshire; Manhattan and Melville, New York; Washington D.C.; and Chicago, Illinois. Customers Bancorp, Inc. was founded in 1997 and is headquartered in West Reading, Pennsylvania.

NYSE ended the session with Customers Bancorp rising 6.38% to $57.23 on Wednesday while NYSE jumped 0.77% to $16,784.82.

Earnings Per Share

As for profitability, Customers Bancorp has a trailing twelve months EPS of $6.32.

PE Ratio

Customers Bancorp has a trailing twelve months price to earnings ratio of 9.06. Meaning, the purchaser of the share is investing $9.06 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.7%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 27.1%, now sitting on 613.09M for the twelve trailing months.

Yearly Top and Bottom Value

Customers Bancorp’s stock is valued at $57.23 at 01:32 EST, way below its 52-week low of $6.87.

Sales Growth

Customers Bancorp’s sales growth is 27.9% for the present quarter and 14.6% for the next.

More news about Customers Bancorp.

7. Bionano Genomics (BNGO) – 6.25%

Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; EpiPanelDx PLUS, a genetic testing panel for patients who have experienced seizures, infantile spasms, encephalopathy, or febrile seizures; PGx test, which identifies over 60 alleles in 11 genes. The company was founded in 2003 and is headquartered in San Diego, California.

NASDAQ ended the session with Bionano Genomics rising 6.25% to $1.62 on Wednesday, following the last session’s upward trend. NASDAQ rose 0.66% to $15,003.22, after five sequential sessions in a row of gains, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, Bionano Genomics has a trailing twelve months EPS of $-7.17.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -113.43%.

More news about Bionano Genomics.

8. American Public Education (APEI) – 6.18%

American Public Education, Inc., together with its subsidiaries, provides online and campus-based postsecondary education and career learning. It operates through three segments: American Public University System, Rasmussen University, and Hondros College of Nursing. The company offers 136 degree programs and 115 certificate programs in various fields of study, including nursing, public health, public administration, and business administration. It also provides nursing-and health sciences-focused postsecondary education, diploma in practical nursing, and an associate degree in nursing. The company was incorporated in 1991 and is headquartered in Charles Town, West Virginia.

NASDAQ ended the session with American Public Education rising 6.18% to $8.93 on Wednesday, following the last session’s upward trend. NASDAQ rose 0.66% to $15,003.22, after five consecutive sessions in a row of gains, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, American Public Education has a trailing twelve months EPS of $-3.9.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -22.4%.

Sales Growth

American Public Education’s sales growth is negative 1.3% for the current quarter and 0.6% for the next.

Volume

Today’s last reported volume for American Public Education is 28298 which is 55.6% below its average volume of 63736.

More news about American Public Education.

9. Pacific Biosciences of California (PACB) – 6.15%

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. The company serves research institutions; commercial laboratories; genome centers; public health labs, hospitals and clinical research institutes, contract research organizations, and academic institutions; pharmaceutical companies; and agricultural companies. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

NASDAQ ended the session with Pacific Biosciences of California jumping 6.15% to $9.76 on Wednesday, after two successive sessions in a row of losses. NASDAQ rose 0.66% to $15,003.22, after five successive sessions in a row of gains, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, Pacific Biosciences of California has a trailing twelve months EPS of $-1.27.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -44.46%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 24.3% and 27.8%, respectively.

Sales Growth

Pacific Biosciences of California’s sales growth is 103.7% for the ongoing quarter and 59.2% for the next.

Volatility

Pacific Biosciences of California’s last week, last month’s, and last quarter’s current intraday variation average was 4.47%, 0.64%, and 4.02%.

Pacific Biosciences of California’s highest amplitude of average volatility was 6.94% (last week), 3.10% (last month), and 4.02% (last quarter).

Earnings Before Interest, Taxes, Depreciation, and Amortization

Pacific Biosciences of California’s EBITDA is 15.02.

More news about Pacific Biosciences of California.

10. Groupon (GRPN) – 5.69%

Groupon, Inc., together with its subsidiaries, operates a marketplace that connects consumers to merchants. It operates in two segments, North America and International. The company sells goods or services on behalf of third-party merchants; and first-party goods inventory. It serves customers through its mobile applications and websites. The company was formerly known as ThePoint.com, Inc. and changed its name to Groupon, Inc. in October 2008. Groupon, Inc. was incorporated in 2008 and is headquartered in Chicago, Illinois.

NASDAQ ended the session with Groupon jumping 5.69% to $11.67 on Wednesday, after three consecutive sessions in a row of losses. NASDAQ rose 0.66% to $15,003.22, after five consecutive sessions in a row of gains, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, Groupon has a trailing twelve months EPS of $-4.5.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -567.07%.

Volatility

Groupon’s last week, last month’s, and last quarter’s current intraday variation average was 0.05%, 1.01%, and 5.25%.

Groupon’s highest amplitude of average volatility was 1.80% (last week), 2.00% (last month), and 5.25% (last quarter).

Moving Average

Groupon’s value is under its 50-day moving average of $11.74 and way above its 200-day moving average of $8.17.

Revenue Growth

Year-on-year quarterly revenue growth declined by 12.4%, now sitting on 525.35M for the twelve trailing months.

More news about Groupon.

Losers Today

1. CorEnergy Infrastructure Trust (CORR) – -11.32%

CorEnergy Infrastructure Trust, Inc. (NYSE: CORR, CORRPrA), is a real estate investment trust (REIT) that owns critical energy assets, such as pipelines, storage terminals, and transmission and distribution assets. We receive long-term contracted revenue from customers and operators of our assets, including triple-net participating leases and from long term customer contracts.

NYSE ended the session with CorEnergy Infrastructure Trust falling 11.32% to $0.19 on Wednesday, after four sequential sessions in a row of gains. NYSE rose 0.77% to $16,784.82, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, CorEnergy Infrastructure Trust has a trailing twelve months EPS of $-1.52.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.75%.

Volume

Today’s last reported volume for CorEnergy Infrastructure Trust is 18462 which is 78.3% below its average volume of 85080.

More news about CorEnergy Infrastructure Trust.

2. FuelCell Energy (FCEL) – -8.5%

FuelCell Energy, Inc., together with its subsidiaries, manufactures and sells stationary fuel cell energy platforms that decarbonize power and produce hydrogen. It offers SureSource 1500, a 1.4-megawatt (MW) platform; SureSource 3000, a 2.8 MW platform; SureSource 4000, a 3.7 MW platform; SureSource 250, a 250- kilowatt (kW) platform; SureSource 400, a 400-kW platform; and SureSource Hydrogen, a 2.3 MW platform that is designed to produce up to 1,200 kilograms of hydrogen per day for multi-megawatt utility, microgrid, and distributed hydrogen applications, as well as on-site heat and chilling applications. The company also provides SureSource platform in various configurations and applications, including on-site power, utility grid support, and microgrid, as well as distributed hydrogen; solutions for long duration hydrogen-based energy storage and electrolysis technology; and carbon capture, separation, and utilization systems. Its SureSource power plants generate electricity, heat, hydrogen, and water. In addition, the company provides turn-key solutions, including development, engineering, procurement, construction, interconnection, and operation services. It serves various markets, including utilities and independent power producers, industrial and process applications, education and health care, data centers and communication, wastewater treatment, government, microgrids, hydrogen transportation, food and beverage, and commercial and hospitality. The company primarily operates in the United States, South Korea, England, Germany, and Switzerland. FuelCell Energy, Inc. was founded in 1969 and is headquartered in Danbury, Connecticut.

NASDAQ ended the session with FuelCell Energy falling 8.5% to $1.40 on Wednesday while NASDAQ rose 0.66% to $15,003.22.

Earnings Per Share

As for profitability, FuelCell Energy has a trailing twelve months EPS of $-0.3.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -15.79%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 40.8%, now sitting on 140.13M for the twelve trailing months.

Sales Growth

FuelCell Energy’s sales growth for the current quarter is negative 35.8%.

Volume

Today’s last reported volume for FuelCell Energy is 14093000 which is 15.68% above its average volume of 12182800.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, FuelCell Energy’s stock is considered to be oversold (<=20).

Previous days news about FuelCell Energy

  • Fuelcell energy (fcel) reports Q4 earnings: what key metrics have to say. According to Zacks on Tuesday, 19 December, "Here is how FuelCell Energy performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:"

More news about FuelCell Energy.

3. City Office REIT (CIO) – -7.47%

City Office REIT, Inc. (NYSE: CIO) invests in high-quality office properties in 18-hour cities with strong economic fundamentals, primarily in the Southern and Western United States. At September 30, 2020, CIO owned office complexes comprising 5.8 million square feet of net rentable area (“NRA”).

NYSE ended the session with City Office REIT falling 7.47% to $5.82 on Wednesday while NYSE rose 0.77% to $16,784.82.

Earnings Per Share

As for profitability, City Office REIT has a trailing twelve months EPS of $-0.47.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.46%.

Moving Average

City Office REIT’s value is way above its 50-day moving average of $4.48 and way higher than its 200-day moving average of $5.23.

More news about City Office REIT.

4. Chesapeake Granite Wash Trust (CHKR) – -6.42%

Chesapeake Granite Wash Trust owns royalty interests in oil, natural gas liquids, and natural gas properties located in the Colony Granite Wash play in Washita County in the Anadarko Basin of Western Oklahoma. The company has royalty interests in 69 producing wells and 118 development wells, and in approximately 26,400 net acres of area. As of December 31, 2020, its reserve estimates for the royalty interests included 2,736 thousand barrels of oil equivalent of proved developed reserves. Chesapeake Granite Wash Trust was founded in 2011 and is based in Houston, Texas.

NYSE ended the session with Chesapeake Granite Wash Trust dropping 6.42% to $0.62 on Wednesday, after two sequential sessions in a row of losses. NYSE jumped 0.77% to $16,784.82, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, Chesapeake Granite Wash Trust has a trailing twelve months EPS of $0.28.

PE Ratio

Chesapeake Granite Wash Trust has a trailing twelve months price to earnings ratio of 2.21. Meaning, the purchaser of the share is investing $2.21 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 122.68%.

Volume

Today’s last reported volume for Chesapeake Granite Wash Trust is 38109 which is 42.63% below its average volume of 66430.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Aug 17, 2023, the estimated forward annual dividend rate is 0.21 and the estimated forward annual dividend yield is 20.82%.

Yearly Top and Bottom Value

Chesapeake Granite Wash Trust’s stock is valued at $0.62 at 01:32 EST, way below its 52-week high of $1.30 and way above its 52-week low of $0.31.

More news about Chesapeake Granite Wash Trust.

5. Atrion (ATRI) – -6.08%

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Its cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. The company's ophthalmic products consist of specialized medical devices that include disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. It manufactures products for safe needle and scalpel blade containment; inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

NASDAQ ended the session with Atrion dropping 6.08% to $340.00 on Wednesday while NASDAQ rose 0.66% to $15,003.22.

Earnings Per Share

As for profitability, Atrion has a trailing twelve months EPS of $12.05.

PE Ratio

Atrion has a trailing twelve months price to earnings ratio of 28.22. Meaning, the purchaser of the share is investing $28.22 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.76%.

Moving Average

Atrion’s value is higher than its 50-day moving average of $337.01 and way under its 200-day moving average of $496.44.

More news about Atrion.

6. Coeur Mining (CDE) – -3.95%

Coeur Mining, Inc. explores for, develops, produces, and sells precious metals in the United States, Canada, and Mexico. The company primarily explores for gold, silver, zinc, and lead properties. It holds 100% interests in the Palmarejo gold and silver mine covering an area of approximately 67,296 net acres located in the State of Chihuahua in Northern Mexico; the Rochester silver and gold mine that covers an area of approximately 17,044 net acres situated in northwestern Nevada; the Kensington gold mine comprising 12,336 net acres located to the north of Juneau, Alaska; the Wharf gold mine covering an area of approximately 7,852 net acres situated in the northern Black Hills of western South Dakota; and the Silvertip silver-zinc-lead mine comprising 98,834 net acres located in northern British Columbia, Canada. The company also owns interests in the Crown and Sterling projects located in southern Nevada; and the La Preciosa project located in Mexico. It markets and sells its concentrates to third-party refiners, smelters, and off-take customers. The company was formerly known as Coeur d'Alene Mines Corporation and changed its name to Coeur Mining, Inc. in May 2013. Coeur Mining, Inc. was incorporated in 1928 and is headquartered in Chicago, Illinois.

NYSE ended the session with Coeur Mining dropping 3.95% to $3.40 on Wednesday while NYSE jumped 0.77% to $16,784.82.

Earnings Per Share

As for profitability, Coeur Mining has a trailing twelve months EPS of $-0.05.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -3.1%.

Yearly Top and Bottom Value

Coeur Mining’s stock is valued at $3.40 at 01:32 EST, way below its 52-week high of $4.55 and way above its 52-week low of $2.00.

Moving Average

Coeur Mining’s worth is way above its 50-day moving average of $2.68 and way higher than its 200-day moving average of $2.92.

More news about Coeur Mining.

7. Coeur Mining (CDE) – -3.95%

Coeur Mining, Inc. explores for, develops, produces, and sells precious metals in the United States, Canada, and Mexico. The company primarily explores for gold, silver, zinc, and lead properties. It holds 100% interests in the Palmarejo gold and silver mine covering an area of approximately 67,296 net acres located in the State of Chihuahua in Northern Mexico; the Rochester silver and gold mine that covers an area of approximately 17,044 net acres situated in northwestern Nevada; the Kensington gold mine comprising 12,336 net acres located to the north of Juneau, Alaska; the Wharf gold mine covering an area of approximately 7,852 net acres situated in the northern Black Hills of western South Dakota; and the Silvertip silver-zinc-lead mine comprising 98,834 net acres located in northern British Columbia, Canada. The company also owns interests in the Crown and Sterling projects located in southern Nevada; and the La Preciosa project located in Mexico. It markets and sells its concentrates to third-party refiners, smelters, and off-take customers. The company was formerly known as Coeur d'Alene Mines Corporation and changed its name to Coeur Mining, Inc. in May 2013. Coeur Mining, Inc. was incorporated in 1928 and is headquartered in Chicago, Illinois.

NYSE ended the session with Coeur Mining sliding 3.95% to $3.40 on Wednesday, following the last session’s downward trend. NYSE jumped 0.77% to $16,784.82, following the last session’s upward trend on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, Coeur Mining has a trailing twelve months EPS of $-0.05.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -3.1%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 100% and 100%, respectively.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Coeur Mining’s EBITDA is 2.29.

Moving Average

Coeur Mining’s worth is way higher than its 50-day moving average of $2.68 and way above its 200-day moving average of $2.92.

More news about Coeur Mining.

8. China Green Agriculture (CGA) – -3.8%

China Green Agriculture, Inc., through its subsidiaries, engages in the research, development, production, and sale of various fertilizers and agricultural products in the People's Republic of China. The company operates through four segments: Jinong, Gufeng, Yuxing, and Sales VIEs. Its fertilizer products comprise humic acid-based compound fertilizers, blended fertilizers, organic compound fertilizers, slow-release fertilizers, highly concentrated water-soluble fertilizers, and mixed organic-inorganic compound fertilizers, as well as develops, produces, and distributes agricultural products, such as fruits, vegetables, flowers, and colored seedlings. The company markets its fertilizer products to private wholesalers and retailers of agricultural farm products. It sells its decorative flowers to end-users, such as flower shops, luxury hotels, and government agencies; fruits and vegetables to supermarkets and upscale restaurants; and seedlings to city planning departments. As of June 30, 2021, the company operated a network of 1,756 distributors covering 22 provinces, 4 autonomous regions, and 4 central government-controlled municipalities in China. It also exports its products through contracted distributors to various countries, including India and Africa. China Green Agriculture, Inc. was incorporated in 1987 and is based in Xi'an, the People's Republic of China.

NYSE ended the session with China Green Agriculture falling 3.8% to $2.02 on Wednesday, following the last session’s downward trend. NYSE jumped 0.77% to $16,784.82, following the last session’s upward trend on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, China Green Agriculture has a trailing twelve months EPS of $-1.09.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -11.06%.

Yearly Top and Bottom Value

China Green Agriculture’s stock is valued at $2.02 at 01:32 EST, way under its 52-week high of $4.50 and way above its 52-week low of $1.61.

More news about China Green Agriculture.

9. FAT Brands (FAT) – -3.44%

FAT Brands Inc., a multi-brand restaurant company, acquires, develops, markets, and manages quick service, fast casual, casual dining, and polished casual dining restaurant concepts worldwide. It owns restaurant brands, including Round Table Pizza, Marble Slab Creamery, Great American Cookies, Hot Dog on a Stick, Pretzelmaker, Fazoli's, Fatburger, Johnny Rockets, Elevation Burger, Yalla Mediterranean, Buffalo's Cafe and Buffalo's Express, Hurricane Grill & Wings, Ponderosa Steakhouse / Bonanza Steakhouse, Native Grill & Wings, and Twin Peaks. The company was incorporated in 2017 and is headquartered in Beverly Hills, California. FAT Brands Inc. operates as a subsidiary of Fog Cutter Holdings, LLC.

NASDAQ ended the session with FAT Brands dropping 3.44% to $6.18 on Wednesday while NASDAQ jumped 0.66% to $15,003.22.

Earnings Per Share

As for profitability, FAT Brands has a trailing twelve months EPS of $-8.16.

More news about FAT Brands.

10. Lyft (LYFT) – -3.13%

Lyft, Inc. operates a peer-to-peer marketplace for on-demand ridesharing in the United States and Canada. The company operates multimodal transportation networks that offer riders personalized and on-demand access to various mobility options. It provides Ridesharing Marketplace, which connects drivers with riders; Express Drive, a flexible car rentals program for drivers; Lyft Rentals that provides vehicles for long-distance trips; and a network of shared bikes and scooters in various cities to address the needs of riders for short trips. The company also integrates third-party public transit data into the Lyft app to offer riders various transportation options. In addition, it offers access to autonomous vehicles; centralized tools and enterprise transportation solutions, such as concierge transportation solutions for organizations; Lyft Pink subscription plans; Lyft Pass commuter programs; first-mile and last-mile services; and university safe rides programs. The company was formerly known as Zimride, Inc. and changed its name to Lyft, Inc. in April 2013. Lyft, Inc. was incorporated in 2007 and is headquartered in San Francisco, California.

NASDAQ ended the session with Lyft falling 3.13% to $15.15 on Wednesday while NASDAQ jumped 0.66% to $15,003.22.

Earnings Per Share

As for profitability, Lyft has a trailing twelve months EPS of $-2.45.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -146.23%.

More news about Lyft.

Stay up to date with our winners and losers daily report

Leave a Reply

Your email address will not be published. Required fields are marked *